The pharmaceutical industry operates under the highest standards of quality and safety. For R&D scientists and procurement specialists, ensuring the purity and quality of chemical intermediates is not just a procedural step, but a fundamental requirement for successful drug development and manufacturing. This article highlights the importance of stringent quality control, focusing on a key intermediate: 5-(2-chloroethyl)-2,3-dihydro-1-benzofuran (CAS: 943034-50-2).
The Non-Negotiable Role of Purity
Pharmaceutical intermediates are the building blocks of Active Pharmaceutical Ingredients (APIs). Any impurity or deviation in the chemical structure of an intermediate can have cascading effects on the final API's efficacy, safety profile, and stability. For example, 5-(2-chloroethyl)-2,3-dihydro-1-benzofuran, used in the synthesis of Darifenacin, must meet precise specifications. A typical high-quality product will present as a white crystalline powder with an assay of ≥98.0% as determined by High-Performance Liquid Chromatography (HPLC). Low moisture content, usually ≤1.0%, is also a critical parameter to ensure product integrity during storage and reaction.
Key Quality Control Parameters
When sourcing intermediates, it is crucial to work with suppliers who implement robust quality control measures. For 5-(2-chloroethyl)-2,3-dihydro-1-benzofuran, essential QC parameters include:
Supplier Selection and Verification
For procurement managers looking to buy this intermediate, selecting a supplier with strong quality assurance protocols is paramount. Manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. emphasize these quality aspects. When evaluating suppliers, inquire about:
Impact on API Manufacturing
The consistent supply of high-purity 5-(2-chloroethyl)-2,3-dihydro-1-benzofuran directly contributes to the efficiency and reliability of Darifenacin API manufacturing. By prioritizing quality control from the intermediate stage, pharmaceutical companies can mitigate risks, reduce batch failures, and ensure the final drug product meets all regulatory and patient safety requirements.
In conclusion, understanding and demanding rigorous quality control, particularly concerning purity, for pharmaceutical intermediates is a cornerstone of responsible drug manufacturing. Partnering with suppliers who share this commitment ensures the integrity of your entire production process.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.